United States · FDA National Drug Code directory
Zolmitriptan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-182_052016e5-acea-4d2a-8d76-cef36eb99262
- Product NDC
- 46708-182
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Zolmitriptan
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161201
- Source listing expiry
- 20261231
Source-listed ingredients
- ZOLMITRIPTAN — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (46708-182-03) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 46708-182-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →